MedTrace Logo

Video Game Hearing Tests for Remote Monitoring of Ototoxicity

NCT05847556 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2023-05-12

No results posted yet for this study

Summary

The reason for this clinical trial is to test different ways of carrying out hearing tests to be able to detect for hearing loss within the hospital and at home.

Pathway 1:

The goal of this clinical trial is to learn whether video game hearing tests work well to detect hearing loss caused by antibiotics at home in patients with long-term lung infections.

Pathway 2:

The goal of this clinical trial is to compare tablet-based (iPad) hearing tests with formal sound booth hearing tests in patients attending hospital outpatient clinics.

Pathway 3:

The goal of this clinical trial is to learn whether audio-training improves listening to speech in the presence of background noise. Researchers will compare participants receiving audio-training with those who did not receive audio-training. This will test if audio-training can improve participant's everyday listening experiences.

Conditions

  • Aminoglycoside Toxicity
  • Aminoglycoside-Induced Hearing Loss
  • Hearing Loss
  • Video Games

Interventions

OTHER

video game hearing tests

Video game hearing tests (as a non-medical device) used to monitor ototoxicity

OTHER

Audio-training

Audio-training (as a non-medical device) used to determine if it can improve spatial hearing perception.

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Anand Shah · Imperial College London

  • Francis Drobniewski · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-16
Primary Completion
2023-09-15
Completion
2023-09-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05847556 on ClinicalTrials.gov